These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33064135)

  • 1. Human Prion Disease Surveillance in Washington State, 2006-2017.
    Sánchez-González L; Maddox RA; Lewis LC; Blevins JE; Harker EJ; Appleby BS; Person MK; Schonberger LB; Belay ED; DeBolt C; Lofy KH
    JAMA Netw Open; 2020 Oct; 3(10):e2020690. PubMed ID: 33064135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2018.
    Stehmann C; Senesi M; Lewis V; Ummi M; Simpson M; Klug G; McLean C; Masters C; Collins S
    Commun Dis Intell (2018); 2019 Aug; 43():. PubMed ID: 31426734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creutzfeldt–Jakob disease surveillance in Australia: update to December 2017.
    Stehmann C; Sarros S; Senesi M; Lewis V; Simpson M; McLean C; Masters C; Collins S
    Commun Dis Intell (2018); 2019 Jul; 43():. PubMed ID: 31315315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion diseases with a focus on Creutzfeldt-Jakob disease, a summary of the incidence of Creutzfeldt-Jakob disease in the Czech Republic over the last 17 years, 2000-2017.
    Kolářová K; Marešová M; Manďáková Z; Kynčl J
    Epidemiol Mikrobiol Imunol; 2018; 67(4):155-160. PubMed ID: 30630318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human prion diseases: the Hungarian experience].
    Kovács GG; Bakos A; Mitrova E; Minárovits J; László L; Majtényi K
    Ideggyogy Sz; 2007 Nov; 60(11-12):447-52. PubMed ID: 18200749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020.
    Stehmann C; Senesi M; Sarros S; McGlade A; Lewis V; Simpson M; Klug G; McLean CA; Masters CL; Collins SJ
    Commun Dis Intell (2018); 2021 Jul; 45():. PubMed ID: 34315360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2022.
    Stehmann C; Senesi M; Sarros S; McGlade A; Lewis V; Ellett L; Barber D; Simpson M; Klug G; McLean CA; Masters CL; Collins SJ
    Commun Dis Intell (2018); 2023 Jun; 47():. PubMed ID: 37357180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective 10-year surveillance of human prion diseases in Japan.
    Nozaki I; Hamaguchi T; Sanjo N; Noguchi-Shinohara M; Sakai K; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Moriwaka F; Shiga Y; Kuroiwa Y; Nishizawa M; Kuzuhara S; Inuzuka T; Takeda M; Kuroda S; Abe K; Murai H; Murayama S; Tateishi J; Takumi I; Shirabe S; Harada M; Sadakane A; Yamada M
    Brain; 2010 Oct; 133(10):3043-57. PubMed ID: 20855418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96.
    Cousens SN; Zeidler M; Esmonde TF; De Silva R; Wilesmith JW; Smith PG; Will RG
    BMJ; 1997 Aug; 315(7105):389-95. PubMed ID: 9277601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013.
    Klug GM; Boyd A; Sarros S; Stehmann C; Simpson M; McLean CA; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E348-55. PubMed ID: 25631598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Washington statewide pathology surveillance for prion disease.
    Allen CT; Sonnen J; Leslie MJ; Kidoguchi L; Harris C; Gambetti P; Montine TJ
    Ann Neurol; 2007 Apr; 61(4):371-2. PubMed ID: 17358023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2019.
    Stehmann C; Senesi M; Sarros S; McGlade A; Simpson M; Klug G; McLean C; Masters CL; Collins S
    Commun Dis Intell (2018); 2020 Jul; 44():. PubMed ID: 32664829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.
    Jackson GS; Burk-Rafel J; Edgeworth JA; Sicilia A; Abdilahi S; Korteweg J; Mackey J; Thomas C; Wang G; Schott JM; Mummery C; Chinnery PF; Mead S; Collinge J
    JAMA Neurol; 2014 Apr; 71(4):421-8. PubMed ID: 24590363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.
    Denouel A; Brandel JP; Peckeu-Abboud L; Seilhean D; Bouaziz-Amar E; Quadrio I; Oudart JB; Lehmann S; Bellecave P; Laplanche JL; Haik S
    Euro Surveill; 2023 Dec; 28(50):. PubMed ID: 38099349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2021.
    Stehmann C; Senesi M; Sarros S; McGlade A; Lewis V; Simpson M; Klug G; McLean C; Masters CL; Collins S
    Commun Dis Intell (2018); 2022 Aug; 46():. PubMed ID: 35981813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
    Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
    Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prion diseases in the United States.
    Holman RC; Belay ED; Christensen KY; Maddox RA; Minino AM; Folkema AM; Haberling DL; Hammett TA; Kochanek KD; Sejvar JJ; Schonberger LB
    PLoS One; 2010 Jan; 5(1):e8521. PubMed ID: 20049325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological surveillance of Creutzfeldt-Jakob in France].
    Brandel JP; Salomon D; Capek I; Vaillant V; Alpérovitch A
    Rev Neurol (Paris); 2009; 165(8-9):684-93. PubMed ID: 19467685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.